• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB); CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB); CATHETER, PERCUTANEOUS Back to Search Results
Catalog Number MOB37
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Perforation of Vessels (2135)
Event Date 08/07/2019
Event Type  Injury  
Manufacturer Narrative
510k #: k172567.Per the gore® molding & occlusion balloon catheter instructions for use, adverse events that may occur and/or require intervention include but are not limited to trauma to the vessel wall, including spasm, dissection, perforation or rupture.
 
Event Description
On (b)(6) 2019, the patient underwent an endovascular repair of an abdominal aortic aneurysm.After all stent grafts were advanced and deployed, touch-up ballooning was performed using a gore® molding & occlusion balloon (mob37/ lot unknown).After ballooning, procedural angiography reportedly revealed a right common iliac artery rupture.A decrease in the patient¿s blood pressure was also reportedly noted.The physician reportedly attributed the rupture of the right common iliac artery to the touch-up ballooning.It was also reported that there was a dissection in the patient¿s right common iliac artery prior to the procedure.The right internal iliac artery was embolized with coils, and additional contralateral leg component was placed in the right external iliac artery to treat the rupture.According to the report, no blood transfusion was required.Final angiography revealed a type ii endoleak.The physician elected to take a wait-and-watch approach in regard to the endoleak, and the procedure was concluded without any further reported complications.The patient tolerated the procedure.
 
Manufacturer Narrative
D4: updated device information (lot, expiration date, udi).H4: updated device manufacture date.H6: updated method and result codes.H6: conclusion codes remain unchanged.Per the gore® molding & occlusion balloon catheter instructions for use, adverse events that may occur and/or require intervention include but are not limited to trauma to the vessel wall, including spasm, dissection, perforation or rupture.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB)
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8884084
MDR Text Key154269895
Report Number3007284313-2019-00248
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2021
Device Catalogue NumberMOB37
Device Lot Number20553200
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
-
-